134 related articles for article (PubMed ID: 1726532)
21. Migratory responses of ovine neutrophils to inflammatory mediators in vitro and in vivo.
Mulder K; Colditz IG
J Leukoc Biol; 1993 Mar; 53(3):273-8. PubMed ID: 8384237
[TBL] [Abstract][Full Text] [Related]
22. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
23. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
[TBL] [Abstract][Full Text] [Related]
24. Depressed leukotriene B4 chemotactic response of neutrophils from localized juvenile periodontitis patients.
Offenbacher S; Scott SS; Odle BM; Wilson-Burrows C; Van Dyke TE
J Periodontol; 1987 Sep; 58(9):602-6. PubMed ID: 2821216
[TBL] [Abstract][Full Text] [Related]
25. The effects of a novel resuscitation strategy combining pentoxifylline and hypertonic saline on neutrophil MAPK signaling.
Deree J; Melbostad H; Loomis WH; Putnam JG; Coimbra R
Surgery; 2007 Aug; 142(2):276-83. PubMed ID: 17689696
[TBL] [Abstract][Full Text] [Related]
26. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow.
Jagels MA; Hugli TE
J Immunol; 1992 Feb; 148(4):1119-28. PubMed ID: 1310708
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
29. F-actin network formation in tethers and in pseudopods stimulated by chemoattractant.
Zhelev DV; Alteraifi AM; Hochmuth RM
Cell Motil Cytoskeleton; 1996; 35(4):331-44. PubMed ID: 8956004
[TBL] [Abstract][Full Text] [Related]
30. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
Wenzel-Seifert K; Grünbaum L; Seifert R
J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
[TBL] [Abstract][Full Text] [Related]
31. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
Palmantier R; Borgeat P
Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
[TBL] [Abstract][Full Text] [Related]
32. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
Patrick RA; Peters PA; Issekutz AC
Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
[TBL] [Abstract][Full Text] [Related]
33. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
34. Chemotaxis of blood neutrophils from patients with primary ciliary dyskinesia.
Koh YY; Sun YH; Min YG; Chi JG; Kim CK
J Korean Med Sci; 2003 Feb; 18(1):36-41. PubMed ID: 12589084
[TBL] [Abstract][Full Text] [Related]
35. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils.
Sitrin RG; Emery SL; Sassanella TM; Blackwood RA; Petty HR
J Immunol; 2006 Dec; 177(11):8177-84. PubMed ID: 17114494
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.
Dahinden CA; Zingg J; Maly FE; de Weck AL
J Exp Med; 1988 Apr; 167(4):1281-95. PubMed ID: 2833556
[TBL] [Abstract][Full Text] [Related]
37. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
38. Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.
Krump E; Lemay G; Borgeat P
Br J Pharmacol; 1996 Apr; 117(8):1639-44. PubMed ID: 8732271
[TBL] [Abstract][Full Text] [Related]
39. Synchronous free Ca2+ changes in individual neutrophils stimulated by leukotriene B4.
Davies EV; Campbell AK; Hallett MB
FEBS Lett; 1991 Oct; 291(1):135-8. PubMed ID: 1657634
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of tumor necrosis factor-alpha-induced priming of fMet-Leu-Phe-stimulated neutrophils by pentoxifylline.
Dunzendorfer S; Schratzberger P; Reinisch N; Kähler CM; Wiedermann CJ
Immunol Lett; 1997 Jul; 58(2):75-8. PubMed ID: 9271316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
